Compare AbCellera Biologics Inc (ABCL) vs iShares MSCI Taiwan ETF (EWT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs iShares MSCI Taiwan ETF — how do they compare? AbCellera Biologics Inc trades at $9.3 (market cap $2.99B), while iShares MSCI Taiwan ETF trades at $106.14. Which is the better fit depends on your goals.
| ABCL | EWT | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $9.76 | $111.53 |
52-Week Low | $2.78 | $58.05 |
Enterprise Value | $2.58B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About iShares MSCI Taiwan ETF
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →
